OptiNose, Inc. Contracts & Agreements

106 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated as of September 15, 2016, by and between OptiNose US, Inc. and Thomas E. Gibbs
OptiNose, Inc.
Pharmaceuticals
DE
2017
Employment Agreement, Dated October 4, 2024, between OptiNose US, Inc. and P. Terrence Kohler, Jr
Employment Agreements
OptiNose, Inc.
2024
Amendment No. 1 to Manufacture and Supply Agreement, dated June 7, 2024, by and between OptiNose US, Inc. and Hikma Pharmaceuticals USA Inc
Supply Agreements
OptiNose, Inc.
2024
Amendment No. 2 to Manufacture and Supply Agreement, dated May 20, 2024, by and between OptiNose US, Inc. and Contract Pharmaceuticals Limited Canada
Supply Agreements
OptiNose, Inc.
2024
Manufacture and Supply Agreement, dated December 11, 2020, by and between OptiNose US, Inc. and Hikma Pharmaceuticals USA, Inc
Supply Agreements
OptiNose, Inc.
2024
Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
OptiNose, Inc.
2024
Form of Securities Purchase Agreement
Purchase Agreements
OptiNose, Inc.
2024
Third Amendment to t
OptiNose, Inc.
2024
Second Amendment to the
OptiNose, Inc.
2024
Description of Securities of OptiNose, Inc
OptiNose, Inc.
2024
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
2024
First Amendment and Waiver to the Note Purchase Agreement
Note Agreements
OptiNose, Inc.
2024
Amendment No. 1, dated December 18, 2023, to Supply Agreement, dated July 1, 2017, between OptiNose US, Inc. and Hovione Inter Ltd
Supply Agreements
OptiNose, Inc.
2023
Consulting Agreement, dated June 8, 2023, between OptiNose
Consulting Agreements
OptiNose, Inc.
2023
Amended and Restated Employment Agreement, dated May
Employment Agreements
OptiNose, Inc.
2023
Amended and Restated Employment Agreement, dated May
Employment Agreements
OptiNose, Inc.
2023
Amended and Restated Employment Agreement, dated Ma
Employment Agreements
OptiNose, Inc.
2023
Amended and Restated Employment Agreement, dated Ma
Employment Agreements
OptiNose, Inc.
2023
Description of Securities of OptiNose, Inc
OptiNose, Inc.
Pharmaceuticals
2023
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2023
Amended and Restated Employment Agreement, dated January 30, 2023, between OptiNose US, Inc. and Ramy A. Mahmoud
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2023
Form of Separation Agreement and General Release
Separation Agreements
OptiNose, Inc.
2023
Consulting Agreement, dated January 3
Consulting Agreements
OptiNose, Inc.
2023
Consulting Agreement, dated December 16, 2022, between OptiNose US, Inc. and
Consulting Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2022
Employment Agreement, dated December 15, 2022, between OptiNose US, Inc. and Paul Spence, Jr
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2022
Underwriting Agreement, dated November 21, 2022, by and between OptiNose, Inc. and Piper Sandler & Co
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Form of Warrant
Warrant Agreements
OptiNose, Inc.
2022
Warrant Agency Agreement, dated November 23, 2022, by and between OptiNose, Inc. and Broadridge Corporate Issuer Solutions, Inc
Warrant Agreements
OptiNose, Inc.
2022
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2022
Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
2022
Fourth Amendment, dated November 9, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2022
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2022
Third Amendment, dated August 10, 2022, to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS,...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2022
Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors...
Cooperation Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2022
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2022
Cooperation Agreement, dated April 25, 2022, by and among OptiNose, Inc. M. Kingdon Offshore Master Fund L.P., Velan Capital Partners LP and certain other affiliated investors...
Cooperation Agreements
OptiNose, Inc.
2022
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
2022
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
OptiNose, Inc.
2022
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2022
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2022
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreements
OptiNose, Inc.
2022
Amended and Restated Employment Agreement, dated March 2, 2022, between OptiNose US, Inc. and Peter K. Miller
Employment Agreements
OptiNose, Inc.
2022
Retention Agreement, dated March 7, 2022, between Michael F. Marino and Optinose US, Inc
Retention Agreements
OptiNose, Inc.
2022
Underwriting Agreement, dated November 16, 2021, by and between OptiNose, Inc. and Piper Sandler & Co
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2021
Form of New Warrant
Warrant Agreements
OptiNose, Inc.
2021
Second Amendment to the Note Purchase Agreement, dated November 16, 2021, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
Pharmaceuticals
2021
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC
OptiNose, Inc.
2021
Open Market Sale Agreement (the Sale Agreement), dated August 11, 2021, between the Company and Jefferies LLC
OptiNose, Inc.
2021
Renewal and Amendment No. 1, dated February 22, 2021 to Manufacture and Supply Agreement, dated as of August 18, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and...
Supply Agreements
OptiNose, Inc.
2021
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
2021
First Amendment to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
2021
Amendment No.1, dated September 15, 2020, to the Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and...
Services Agreements
OptiNose, Inc.
Pharmaceuticals
2020
Underwriting Agreement, dated August 13, 2020, by and between Opti
Underwriting Agreements
OptiNose, Inc.
2020
Amendment Letter to the Note Purchase Agreement, dated September 12, 2019, among OptiNose US, Inc., OptiNose, Inc., OptiNose UK Limited and OptiNose AS, BioPharma Credit PLC, as...
Credit Agreements
OptiNose, Inc.
2020
Form of Restricted Stock Unit Agreement (Inducement Grant)
Stock Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2020
Note dated April 6, 2020, between OptiNose US, Inc. and JPMorgan Chase Bank, N.A
Note Agreements
OptiNose, Inc.
Pharmaceuticals
OH
2020
Description of Securities of OptiNose, Inc
OptiNose, Inc.
Pharmaceuticals
2020
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2020
Underwriting Agreement, dated November 20, 2019, by and between OptiNose, Inc., Jefferies LLC, Cowen and Company, LLC, Piper Jaffray & Co. and the Selling Stockholders named...
Underwriting Agreements
OptiNose, Inc.
2019
Common Stock Warrant issued by Optinose, Inc. dated September 12, 2019
Warrant Agreements
OptiNose, Inc.
2019
Form of Restricted Stock Unit Agreement Under the 2010 Stock Incentive Plan
Bonus & Incentive Agreements
OptiNose, Inc.
2019
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2019
Manufacturing Services Agreement, dated December 21, 2018, by and among OptiNose US, Inc., OptiNose UK Ltd. and Optinose AS and Advance Mold & Manufacturing, Inc. d/b/a Vision...
Services Agreements
OptiNose, Inc.
Pharmaceuticals
2019
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
2018
Form of Underwriting Agreement
Underwriting Agreements
OptiNose, Inc.
2018
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2018
Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Peter K. Miller
Employment Agreements
OptiNose, Inc.
2017
Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Ramy A. Mahmoud
Employment Agreements
OptiNose, Inc.
2017
Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Thomas E. Gibbs
Employment Agreements
OptiNose, Inc.
2017
Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Keith A. Goldan
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2017
Employment Agreement, dated October 12, 2017, between OptiNose US, Inc. and Michael F. Marino
Employment Agreements
OptiNose, Inc.
2017
Form of Underwriting Agreement
Underwriting Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2017
First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
2017
First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
2017
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
2017
Employment Agreement between OptiNose US, Inc. and Peter K. Miller to be in effect upon the closing of this offering
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2017
Employment Agreement between OptiNose US, Inc. and Ramy A. Mahmoud to be in effect upon the closing of this offering
Employment Agreements
OptiNose, Inc.
2017
Employment Agreement between OptiNose US, Inc. and Thomas E. Gibbs to be in effect upon the closing of this offering
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2017
Employment Agreement between OptiNose US, Inc. and Keith A. Goldan to be in effect upon the closing of this offering
Employment Agreements
OptiNose, Inc.
2017
Employment Agreement between OptiNose US, Inc. and Michael F. Marino to be in effect upon the closing of this offering
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
PA
2017
Amended and Restated 2010 Stock Incentive Plan
Bonus & Incentive Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
2017 Employee Stock Purchase Plan
Stock Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
First Amendment to the Second Amended and Restated Shareholders Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
2017
Stockholders' Agreement, dated October 2, 2017, by and among OptiNose, Inc. and certain of its stockholders
OptiNose, Inc.
2017
First Amendment to the Second Amended and Restated Registration Rights Agreement, dated October 2, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
2017
Form of Indemnification Agreement
Indemnification Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Amended and Restated 2010 Stock Incentive Plan
Bonus & Incentive Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan (Relating to Success Pool Grants)
Bonus & Incentive Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan (Relating to Option Pool Grants)
Bonus & Incentive Agreements
OptiNose, Inc.
2017
Form of Non-Qualified Stock Option Agreement Granted Under the 2010 Stock Incentive Plan
Bonus & Incentive Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Form of Non-Qualified Stock Option Agreement to be Granted Under the Amended and Restated 2010 Stock Incentive Plan
Bonus & Incentive Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
2017 Employee Stock Purchase Plan
Stock Agreements
OptiNose, Inc.
2017
Exchange Agreement, dated as of June 7, 2010, by and among the Registrant, OptiNose AS and the other signatories thereto (the Registrant hereby agrees to furnish supplementally a...
Exchange Agreements
OptiNose, Inc.
2017
Second Amended and Restated Registration Rights Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders
Registration Rights Agreements
OptiNose, Inc.
2017
Second Amended and Restated Shareholders' Agreement, dated March 24, 2017, by and among the Registrant and certain of its stockholders
Shareholders Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2017
Form of Warrant issued by the Registrant on June 7, 2010
Warrant Agreements
OptiNose, Inc.
2017
Employment Agreement, dated as of May 27, 2010, by and between the Registrant and Peter K. Miller
Employment Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
Letter Agreement, dated as of June 18, 2010, by and between the Registrant and Ramy A. Mahmoud
OptiNose, Inc.
Pharmaceuticals
DE
2017
Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Keith A. Goldan
OptiNose, Inc.
2017
Letter Agreement, dated as of January 13, 2017, by and between OptiNose US, Inc. and Michael F. Marino
OptiNose, Inc.
Pharmaceuticals
DE
2017
License Agreement, dated as of July 1, 2013, by and between OptiNose AS and Avanir Pharmaceuticals, Inc
License Agreements
OptiNose, Inc.
Pharmaceuticals
DE
2017
First Amendment of License Agreement, dated as of April 25, 2014, by and between OptiNose US, Inc. and Avanir Pharmaceuticals, Inc
License Agreements
OptiNose, Inc.
2017
Amendment to License Agreement, dated as of August 6, 2015, by and between OptiNose AS and Avanir Pharmaceuticals, Inc
License Agreements
OptiNose, Inc.
2017
Supply Agreement, dated July 1, 2017, by and between Hovione Inter Ltd and OptiNose US, Inc., OptiNose UK, Ltd and OptiNose AS
Supply Agreements
OptiNose, Inc.
Pharmaceuticals
NY
2017
Manufacture and Supply Agreement, dated as of August 18, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and OptiNose AS and Contract Pharmaceuticals Limited Canada
Supply Agreements
OptiNose, Inc.
2017
Manufacturing Services Agreement, dated as of August 31, 2017, by and among OptiNose US, Inc., OptiNose UK Ltd. and OptiNose AS and Ximedica, LLC
Services Agreements
OptiNose, Inc.
2017